within Pharmacolibrary.Drugs.G_GenitoUrinarySystemAndSexHormones.G01A_AntiinfectivesAndAntisepticsExclCombinationsWithCorticosteroids.G01AX02_Inosine;

model Inosine
  extends Pharmacolibrary.Drugs.ATC.G.G01AX02;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>G01AX02</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Inosine is a purine nucleoside formed by the deamination of adenosine. It has been used as a medication for various conditions, such as immunomodulation or neuroprotection, but it is not widely approved or in common use today. Its utility in clinical practice is limited and not supported by major regulatory agencies.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic data are available for inosine in humans; the following parameters are estimates based on its structural similarity to adenosine and other nucleosides, as well as general pharmacokinetic principles.</p><h4>References</h4><ol><li><p>Zhou, XJ, et al., &amp; Sommadossi, JP (1999). Population pharmacokinetics of nevirapine, zidovudine, and didanosine in human immunodeficiency virus-infected patients. The National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 Investigators. <i>Antimicrobial agents and chemotherapy</i> 43(1) 121–128. DOI:<a href=\"https://doi.org/10.1128/AAC.43.1.121\">10.1128/AAC.43.1.121</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/9869576/\">https://pubmed.ncbi.nlm.nih.gov/9869576</a></p></li><li><p>Staatz, CE, &amp; Tett, SE (2007). Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients. <i>Clinical pharmacokinetics</i> 46(1) 13–58. DOI:<a href=\"https://doi.org/10.2165/00003088-200746010-00002\">10.2165/00003088-200746010-00002</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/17201457/\">https://pubmed.ncbi.nlm.nih.gov/17201457</a></p></li><li><p>Velasque, LS, et al., &amp; Struchiner, CJ (2007). A new model for the population pharmacokinetics of didanosine in healthy subjects. <i>Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas</i> 40(1) 97–104. DOI:<a href=\"https://doi.org/10.1590/s0100-879x2007000100013\">10.1590/s0100-879x2007000100013</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/17225002/\">https://pubmed.ncbi.nlm.nih.gov/17225002</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial generated model</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Inosine;
